肥厚性・ケロイド性瘢痕治療市場：瘢痕タイプ、製品、用途別-2023-2030年の世界予測

肥厚性・ケロイド性瘢痕治療の世界市場は、2023年にCAGR14.26%で16億7,909万米ドルが予測され、2030年には42億8,829万米ドルに達するという驚異的な成長を遂げると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の肥厚性・ケロイド性瘢痕治療市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.肥厚性・ケロイド性瘢痕治療の世界市場規模および予測は？

2.予測期間中、世界の肥厚性・ケロイド性瘢痕治療市場を形成するCOVID-19の阻害要因と影響は？

3.肥厚性・ケロイド性瘢痕治療の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.肥厚性・ケロイド性瘢痕治療の世界市場における競争戦略は？

5.肥厚性・ケロイド性瘢痕治療の世界市場における技術動向と規制の枠組みは？

6.肥厚性・ケロイド性瘢痕治療の世界市場における主要ベンダーの市場シェアは？

7.肥厚性・ケロイド性瘢痕治療の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 肥厚性瘢痕やケロイド瘢痕を引き起こす怪我の発生率が増加
    • 美容整形に対する意識の高まり
  • 抑制要因
    • レーザー治療に伴う高額な費用
  • 機会
    • 肥厚性・ケロイド性瘢痕治療に対応したレーザー治療と製品の登場
    • いくつかの局所クリームのイントロダクションと利用可能性
  • 課題
    • 肥厚性・ケロイド性瘢痕治療に関する悪影響と知識不足
• 市場動向
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ

第6章 肥厚性・ケロイド性瘢痕治療市場傷跡の種類別

• 肥厚性瘢痕
• ケロイド傷跡

第7章 肥厚性・ケロイド性瘢痕治療市場：製品別

• 注射剤
• レーザー製品
• 話題の商品

第8章 肥厚性・ケロイド性瘢痕治療市場：最終用途別

• クリニック
• 病院
• 小売薬局とeコマース

第9章 南北アメリカの肥厚性・ケロイド性瘢痕治療市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の肥厚性・ケロイド性瘢痕治療市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの肥厚性・ケロイド性瘢痕治療市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別

第13章 掲載企業一覧

第14章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET RESEARCH PROCESS
• FIGURE 2. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, 2022 VS 2030
• FIGURE 3. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2022 VS 2030 (%)
• FIGURE 5. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
• FIGURE 6. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2022 VS 2030 (%)
• FIGURE 7. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 8. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET DYNAMICS
• FIGURE 9. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. EUROPE, MIDDLE EAST & AFRICA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 17. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 5. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY HYPERTROPHIC SCAR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY KELOID SCAR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY LASER PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY TOPICAL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 12. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY RETAIL PHARMACIES & E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 22. BRAZIL HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 23. BRAZIL HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 25. CANADA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 26. CANADA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. CANADA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 28. MEXICO HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 29. MEXICO HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 31. UNITED STATES HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 32. UNITED STATES HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 35. ASIA-PACIFIC HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 36. ASIA-PACIFIC HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 39. AUSTRALIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 40. AUSTRALIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 42. CHINA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 43. CHINA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. CHINA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 45. INDIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 46. INDIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. INDIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 48. INDONESIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 49. INDONESIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. INDONESIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 51. JAPAN HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 52. JAPAN HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. JAPAN HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 54. MALAYSIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 55. MALAYSIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. MALAYSIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 57. PHILIPPINES HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 58. PHILIPPINES HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. PHILIPPINES HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 60. SINGAPORE HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 61. SINGAPORE HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. SINGAPORE HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 63. SOUTH KOREA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 64. SOUTH KOREA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. SOUTH KOREA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 66. TAIWAN HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 67. TAIWAN HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. TAIWAN HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 69. THAILAND HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 70. THAILAND HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. THAILAND HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 72. VIETNAM HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 73. VIETNAM HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. VIETNAM HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 75. EUROPE, MIDDLE EAST & AFRICA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 76. EUROPE, MIDDLE EAST & AFRICA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 77. EUROPE, MIDDLE EAST & AFRICA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 79. DENMARK HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 80. DENMARK HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. DENMARK HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 82. EGYPT HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 83. EGYPT HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. EGYPT HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 85. FINLAND HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 86. FINLAND HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. FINLAND HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 88. FRANCE HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 89. FRANCE HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. FRANCE HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 91. GERMANY HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 92. GERMANY HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. GERMANY HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 94. ISRAEL HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 95. ISRAEL HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. ISRAEL HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 97. ITALY HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 98. ITALY HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. ITALY HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 100. NETHERLANDS HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 101. NETHERLANDS HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. NETHERLANDS HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 103. NIGERIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 104. NIGERIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. NIGERIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 106. NORWAY HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 107. NORWAY HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. NORWAY HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 109. POLAND HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 110. POLAND HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. POLAND HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 112. QATAR HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 113. QATAR HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. QATAR HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 115. RUSSIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 116. RUSSIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. RUSSIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 118. SAUDI ARABIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 119. SAUDI ARABIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. SAUDI ARABIA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 121. SOUTH AFRICA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 122. SOUTH AFRICA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH AFRICA HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 124. SPAIN HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SPAIN HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. SPAIN HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 127. SWEDEN HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SWEDEN HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. SWEDEN HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 130. SWITZERLAND HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SWITZERLAND HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. SWITZERLAND HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 133. TURKEY HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 134. TURKEY HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. TURKEY HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 136. UNITED ARAB EMIRATES HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 137. UNITED ARAB EMIRATES HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. UNITED ARAB EMIRATES HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 139. UNITED KINGDOM HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY SCAR TYPE, 2018-2030 (USD MILLION)
• TABLE 140. UNITED KINGDOM HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. UNITED KINGDOM HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 142. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 143. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 144. HYPERTROPHIC & KELOID SCAR TREATMENT MARKET LICENSE & PRICING

The Global Hypertrophic & Keloid Scar Treatment Market is forecasted to grow significantly, with a projected USD 1,679.09 million in 2023 at a CAGR of 14.26% and expected to reach a staggering USD 4,288.29 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Hypertrophic & Keloid Scar Treatment Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Hypertrophic & Keloid Scar Treatment Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Scar Type, market is studied across Hypertrophic Scar and Keloid Scar. The Hypertrophic Scar is projected to witness significant market share during forecast period.

Based on Product, market is studied across Injectables, Laser Products, and Topical Products. The Injectables is projected to witness significant market share during forecast period.

Based on End-Use, market is studied across Clinics, Hospitals, and Retail Pharmacies & E-Commerce. The Hospitals is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Hypertrophic & Keloid Scar Treatment Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Hypertrophic & Keloid Scar Treatment Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Hypertrophic & Keloid Scar Treatment Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Hypertrophic & Keloid Scar Treatment Market?

4. What is the competitive strategic window for opportunities in the Global Hypertrophic & Keloid Scar Treatment Market?

5. What are the technology trends and regulatory frameworks in the Global Hypertrophic & Keloid Scar Treatment Market?

6. What is the market share of the leading vendors in the Global Hypertrophic & Keloid Scar Treatment Market?

7. What modes and strategic moves are considered suitable for entering the Global Hypertrophic & Keloid Scar Treatment Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Hypertrophic & Keloid Scar Treatment Market, by Scar Type, 2022 vs 2030
• 4.3. Hypertrophic & Keloid Scar Treatment Market, by Product, 2022 vs 2030
• 4.4. Hypertrophic & Keloid Scar Treatment Market, by End-Use, 2022 vs 2030
• 4.5. Hypertrophic & Keloid Scar Treatment Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidences of injuries causing hypertrophic & keloid scars
    • 5.1.1.2. Rising awareness regarding the aesthetic surgery
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with the laser treatments
  • 5.1.3. Opportunities
    • 5.1.3.1. Emergence of laser therapies and products for hypertrophic & keloid scar treatment
    • 5.1.3.2. Introduction and availability of several topical creams
  • 5.1.4. Challenges
    • 5.1.4.1. Adverse effects and lack of knowledge regarding the hypertrophic & keloid scar treatment
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Hypertrophic & Keloid Scar Treatment Market, by Scar Type

• 6.1. Introduction
• 6.2. Hypertrophic Scar
• 6.3. Keloid Scar

7. Hypertrophic & Keloid Scar Treatment Market, by Product

• 7.1. Introduction
• 7.2. Injectables
• 7.3. Laser Products
• 7.4. Topical Products

8. Hypertrophic & Keloid Scar Treatment Market, by End-Use

• 8.1. Introduction
• 8.2. Clinics
• 8.3. Hospitals
• 8.4. Retail Pharmacies & E-Commerce

9. Americas Hypertrophic & Keloid Scar Treatment Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Hypertrophic & Keloid Scar Treatment Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Hypertrophic & Keloid Scar Treatment Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing